Long-term evaluation of home-based pulmonary rehabilitation in patients with fibrotic idiopathic interstitial pneumonias.
Journal
ERJ open research
ISSN: 2312-0541
Titre abrégé: ERJ Open Res
Pays: England
ID NLM: 101671641
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
18
02
2019
accepted:
19
02
2019
entrez:
12
4
2019
pubmed:
12
4
2019
medline:
12
4
2019
Statut:
epublish
Résumé
Few studies have examined the benefits of pulmonary rehabilitation in patients with fibrotic idiopathic pulmonary pneumonia (f-IIP). Here, we report the results of an observational study in routine clinical practice of home-based pulmonary rehabilitation for f-IIP patients. A total of 112 consecutive patients (61 with idiopathic pulmonary fibrosis and 51 with fibrotic nonspecific interstitial pneumonitis) were enrolled, of whom 65 had mild-to-moderate disease (forced vital capacity (FVC) ≥50% predicted and diffusing capacity of the lung for carbon monoxide ( 6MST strokes, HADS Anxiety score and VSRQ score were each significantly improved at T Home-based pulmonary rehabilitation provides long-term benefits in exercise tolerance, anxiety and QoL for patients with f-IIP. Pulmonary rehabilitation should be prescribed systematically as part of the therapeutic arsenal for these patients.
Sections du résumé
BACKGROUND
BACKGROUND
Few studies have examined the benefits of pulmonary rehabilitation in patients with fibrotic idiopathic pulmonary pneumonia (f-IIP). Here, we report the results of an observational study in routine clinical practice of home-based pulmonary rehabilitation for f-IIP patients.
METHODS
METHODS
A total of 112 consecutive patients (61 with idiopathic pulmonary fibrosis and 51 with fibrotic nonspecific interstitial pneumonitis) were enrolled, of whom 65 had mild-to-moderate disease (forced vital capacity (FVC) ≥50% predicted and diffusing capacity of the lung for carbon monoxide (
RESULTS
RESULTS
6MST strokes, HADS Anxiety score and VSRQ score were each significantly improved at T
CONCLUSIONS
CONCLUSIONS
Home-based pulmonary rehabilitation provides long-term benefits in exercise tolerance, anxiety and QoL for patients with f-IIP. Pulmonary rehabilitation should be prescribed systematically as part of the therapeutic arsenal for these patients.
Identifiants
pubmed: 30972352
doi: 10.1183/23120541.00045-2019
pii: 00045-2019
pmc: PMC6452059
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
Conflict of interest: B. Wallaert reports personal fees from Roche and Boehringer Ingelheim, outside the submitted work. Conflict of interest: L. Duthoit has nothing to disclose. Conflict of interest: E. Drumez has nothing to disclose. Conflict of interest: H. Behal has nothing to disclose. Conflict of interest: L. Wemeau reports personal fees from Roche and Boehringer Ingelheim, outside the submitted work. Conflict of interest: C. Chenivesse has nothing to disclose. Conflict of interest: J-M. Grosbois reports that FormAction Santé received financial support from Adair, France Oxygène, Homeperf, LVL Medical, Orkyn, Santélys, Santeo, SOS Oxygène, Sysmed, VitalAire and ARS Hauts de France, during the conduct of the study.
Références
Eur Respir J. 2001 May;17(5):954-61
pubmed: 11488332
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
Health Qual Life Outcomes. 2008 Jul 02;6:46
pubmed: 18597689
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD006322
pubmed: 18843713
Ann Intern Med. 2008 Dec 16;149(12):869-78
pubmed: 19075206
Int J Chron Obstruct Pulmon Dis. 2009;4:9-18
pubmed: 19436682
Respirology. 2009 Aug;14(6):781-7
pubmed: 19703060
J Clin Psychol. 2009 Nov;65(11):1232-45
pubmed: 19739205
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Rev Mal Respir. 2011 Sep;28(7):e52-7
pubmed: 21943547
Eur Respir J. 2013 Aug;42(2):444-53
pubmed: 23100507
Respir Med. 2013 Mar;107(3):401-7
pubmed: 23261311
Sarcoidosis Vasc Diffuse Lung Dis. 2012 Oct;29(2):107-12
pubmed: 23461072
Chron Respir Dis. 2013 Aug;10(3):127-33
pubmed: 23897928
Chest. 2013 Nov;144(5):1652-1658
pubmed: 23928896
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48
pubmed: 24032382
Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64
pubmed: 24127811
Eur Respir Rev. 2013 Dec;22(130):577-86
pubmed: 24293474
Respir Med. 2014 Jan;108(1):203-10
pubmed: 24332409
N Engl J Med. 2014 May 29;370(22):2083-92
pubmed: 24836312
Lancet Respir Med. 2014 Jul;2(7):566-72
pubmed: 24875841
Cochrane Database Syst Rev. 2014 Oct 06;(10):CD006322
pubmed: 25284270
J Thorac Dis. 2014 Nov;6(11):1606-14
pubmed: 25478201
Lung. 2015 Jun;193(3):345-54
pubmed: 25731736
Semin Respir Crit Care Med. 2015 Aug;36(4):630-8
pubmed: 26238647
Int J Chron Obstruct Pulmon Dis. 2015 Sep 25;10:2037-44
pubmed: 26445534
Int J Chron Obstruct Pulmon Dis. 2016 Mar 29;11:657-63
pubmed: 27099483
Respiration. 2016;91(5):367-73
pubmed: 27216848
Thorax. 2017 Jan;72(1):57-65
pubmed: 27672116
Thorax. 2017 Jul;72(7):610-619
pubmed: 28213592
Respirology. 2017 May;22(4):800-819
pubmed: 28339144
Lancet. 1985 Dec 21-28;2(8469-70):1425-6
pubmed: 2867417
Thorax. 2018 Jan;73(1):29-36
pubmed: 28756402
Lancet Respir Med. 2017 Dec;5(12):968-980
pubmed: 29033267
J Cardiopulm Rehabil Prev. 2018 Sep;38(5):273-278
pubmed: 29351129
Eur Respir Rev. 2018 Feb 7;27(147):null
pubmed: 29436402
Clin Rehabil. 2018 Oct;32(10):1299-1307
pubmed: 29843523
ERJ Open Res. 2018 Jun 11;4(2):null
pubmed: 29900176
Respir Res. 2018 Sep 20;19(1):182
pubmed: 30236104
Eur Respir J Suppl. 1993 Mar;16:1-100
pubmed: 8499052